Basic Information
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity. Its leading combination product candidates include Contrave, which has completed Phase III clinical trials, and Empatic, which has completed Phase II clinical trials.
Orexigen Therapeutics, Inc.
California,United States of America
51~100 people
January 01, 2002
info@orexigen.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios